Furthermore, it has been reported that high serum resistin levels correlate with tumor grade and poor prognosis in CRC patients [60], whereby resistin binds to Toll-like receptor 4 on the colon cancer cell membrane and promotes proinflammatory signalling pathways. The gene discussed is RETN; the disease is neoplasm.